title: [Should adjuvant chemotherapy be also used in Dukes stage B2 colon cancer?].
authors.affiliation: Medizinische Klinik/Gastroenterologie, Abteilung Innere Medizin, Tübingen.
authors.forename: R
authors.initials: R
authors.lastname: Porschen
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use*; D017024:Chemotherapy, Adjuvant; D003110:Colonic Neoplasms / Q000188:drug therapy* / Q000401:mortality / Q000473:pathology; D003131:Combined Modality Therapy; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D006801:Humans; D002955:Leucovorin / Q000008:administration & dosage / Q000009:adverse effects; D009367:Neoplasm Staging; D015996:Survival Rate; D016896:Treatment Outcome
chemical_list: D002955:Leucovorin; D005472:Fluorouracil
vernacular_title: Soll eine adjuvante Chemotherapie auch schon im Stadium Dukes' B2 des Kolonkarzinoms eingesetzt werden?